FDA advisers back tamper-proof version of OxyContin

09/24/2009 | Bloomberg

An FDA panel recommended approval of Purdue Pharma's tamper-proof version of pain drug OxyContin. The formulation has a chemical additive that minimizes the release of oxycodone when the pill is chewed or crushed.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID